Product Information
AUBRA EQ-28 TABLET is a generic product labeled by Afaxys Pharma, LLC, priced at $0.1509 per EA under NDC 50102022023. Its NADAC has been published 406 times since Nov 14, 2018.
FDA first approved this application on Nov 14, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Afaxys Pharma, LLCNDC
50102022023
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA206886FDA Approved
11/14/2016
TE Code
AB1
On Market Since
11/14/2016
Price Statistics
The NADAC for AUBRA EQ-28 TABLET has been published 406 times since Nov 14, 2018, and over the history we have for it it has declined 43.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1509 per EA |
|---|---|
| All-time high | $0.3780 (Sep 11, 2019) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1509 |
| Median price | $0.2011 |
| Average price | $0.2127 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 406 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AUBRA EQ-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUBRA EQ-28 TABLET, manufactured by Afaxys Pharma, LLC, is $0.1509 per EA (NDC 50102022023), effective Aug 19, 2026.
How has the price of AUBRA EQ-28 TABLET changed over time?
Over the history we have for it, the NADAC for AUBRA EQ-28 TABLET has declined 43.6%. It has been tracked across 406 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for AUBRA EQ-28 TABLET?
Since Nov 14, 2018, the NADAC for AUBRA EQ-28 TABLET has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.3780 (Sep 11, 2019), with a median of $0.2011 per EA.
Are there cheaper alternatives to AUBRA EQ-28 TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 25% below AUBRA EQ-28 TABLET.
Who manufactures AUBRA EQ-28 TABLET?
AUBRA EQ-28 TABLET (NDC 50102022023) is labeled by Afaxys Pharma, LLC, and CMS classifies it as a generic product.